Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)

#LifeScienceTour visits BioAgilytix

Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters ...

Read more …
Excellent atmosphere during the visit: Mayor Jan Lindenau, Minister of Economic Affairs Claus Ruhe Madsen and DEHAS Managing Director Jens Mittendorf exchanged ideas together with representatives of Life Science Nord and the Lübeck Economic Development Co
Excellent atmosphere during the visit: Mayor Jan Lindenau, Minister of Economic Affairs Claus Ruhe Madsen and DEHAS Managing Director Jens Mittendorf exchanged ideas together with representatives of Life Science Nord and the Lübeck Economic Development Corporation (from left).

A visit to DEHAS

Together with Schleswig-Holstein's Minister of Economic Affairs Claus Ruhe Madsen, Lübeck's Mayor Jan Lindenau and the Lübeck Economic Development Agency, we visited Life Science Nord ...

Read more …
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...

Read more …
Since many years Birn + Partners is a reliable renowned life science company and today represented in ten countries.
Since many years Birn + Partners is a reliable renowned life science company and today represented in ten countries. (Image: totojang1977|stock.adobe.com / Birn + Partners)

A new member of LSN e.V.: Birn + Partners

Founded in 2013 by Mikkel F. Birn in Denmark, the executive search company is now represented by over 60 consultants and partners in ten countries. ...

Read more …
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping.
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping. (Image: Cellbox Solutions)

Cellbox Solutions Awarded €2.5 Million Grant

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced ...

Read more …
Logo of IDERHA
© IDERHA

IDERHA consortium takes off

The newly formed IDERHA consortium, consisting of academia, industry, health authorities, clinicians, and patient representatives, addresses the obstacles in accessing, integrating and analysing health data ...

Read more …
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19.
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19. (Photo Credit: Alissa Eckert, MSMI; Dan Higgins, MAMS)

tiakis: Treatment of COVID-19

tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...

Read more …
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III.
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III. (Image: ©DESY/CFEL)

Biological specimens imaged with X-rays without damage

A pollen grain showing the nanofoam within or a diatom with the individual geometric structures inside clearly visible: Using high-energy X-rays from the PETRA III ...

Read more …
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus.
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus. ( Picture: © Nico Michaelsen, Evotec SE)

Senator Dr. Melanie Leonhard visits Evotec

Evotec SE announced that new high-throughput screening (“HTS”) facilities at the Company’s headquarters in Hamburg, as well as additional equipment for investigating ...

Read more …
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19.
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19. (Image: ©stock.adobe.com/Gorodenkoff)

tiakis Biotech AG and Northway Biotech collaborate

tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful ...

Read more …
Frank Horling, PhD, Managing Director of BioAgilytix in Hamburg, cuts the ribbon. (Image: © BioAgilytix Europe GmbH)
Frank Horling, PhD, Managing Director of BioAgilytix in Hamburg, cuts the ribbon. (Image: © BioAgilytix Europe GmbH)

BioAgilytix Expands Hamburg Lab

BioAgilytix, a leading global bioanalytical lab, announced the expansion and GMP certification of its facility in Hamburg, Germany. The enhanced footprint and addition ...

Read more …
The surgical team prepares for an upcoming operation.
The 5-person SurgMark team has already developed several surgical and wound healing products and achieved approvals as Class III medical devices in the U.S. and Europe – and is now on the verge of FDA approval with SchurSign®. (Image: © stock.adobe.com/Syda Productions)

Medtech start-up SurgMark aims to enter the US market

 In breast imaging, doctors mark suspicious areas with marker clips. With SchurSign®, the Hamburg-based medical technology start-up SurgMark has developed an innovative tissue marker made ...

Read more …
Job board